Shoulder Osteoarthritis Clinical Trial
Official title:
A Randomized Single-blinded Clinical Trial of the Efficacy of Intra-articular Infiltration of Cingal (Sodium Hyaluronate/Triamcinolone) Versus Cortisone (Triamcinolone) in Patients With Osteoarthritis of the Shoulder.
For patients suffering of osteoarthritis, only analgesic treatments such as anti-inflammatory drugs and cortisone infiltrations provide significant but temporary relief of their pain. The objective is to compare the analgesic effect of 2 infiltrations: Cingal (sodium hyaluronate and triamcinolone) versus cortisone (triamcinolone). It is anticipated that the Cingal infiltration will have a greater analgesic effect than a simple cortisone infiltration in patients with moderate to severe osteoarthritis of the shoulder. Method: - Randomized controlled trial - Monocentric - Randomization will be done using sealed envelopes
Status | Recruiting |
Enrollment | 84 |
Est. completion date | December 2026 |
Est. primary completion date | September 2026 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 20 Years and older |
Eligibility | Inclusion Criteria: - A clinical examination that confirms the radiological diagnosis of moderate to severe primary shoulder osteoarthritis, stage II and above, according to the Samilson-Prieto classification. - Patients aged between 20 and 90 years. - A patient with bilateral shoulder osteoarthritis will choose the side of the infiltration, only one side can be chosen to participate in the study. - The patient must have a clinical pain threshold of a minimum of 4/10 on the visual analogue scale. - The patient must have the cognitive ability to read and fill out the questionnaires. - The patient must be able to read and understand French or English Exclusion Criteria: - Presence of a transfixing rotator cuff tear assessed on MRI. - No previous shoulder reconstruction surgery. - Pregnant woman. - A patient who has received a cortisone infiltration within 6 months prior to the start of the study. - A patient who has received a platelet-rich plasma or a hyaluronic acid infiltration within 12 months prior to the start of the study. - Diagnosis of avascular necrosis. - Disease affecting the studied joint (systemic inflammatory disease, history of septic arthritis, osteonecrosis, etc.) - Suspicion or presence of active local infectious process. - Presence or suspicion of neoplasia or local metastasis. - Severe trauma to the shoulder ( = 3 months) - Significant cognitive impairment or insufficient language proficiency to adequately answer the questionnaires. - Any other serious medical condition that does not allow participation in the study or may be a contraindication to cortisone injection. |
Country | Name | City | State |
---|---|---|---|
Canada | Centre Hospitalier de l'Université de Montréal (CHUM) | Montreal | Quebec |
Lead Sponsor | Collaborator |
---|---|
Centre hospitalier de l'Université de Montréal (CHUM) |
Canada,
Brox JI, Lereim P, Merckoll E, Finnanger AM. Radiographic classification of glenohumeral arthrosis. Acta Orthop Scand. 2003 Apr;74(2):186-9. doi: 10.1080/00016470310013932. — View Citation
Hangody L, Szody R, Lukasik P, Zgadzaj W, Lenart E, Dokoupilova E, Bichovsk D, Berta A, Vasarhelyi G, Ficzere A, Hangody G, Stevens G, Szendroi M. Intraarticular Injection of a Cross-Linked Sodium Hyaluronate Combined with Triamcinolone Hexacetonide (Cingal) to Provide Symptomatic Relief of Osteoarthritis of the Knee: A Randomized, Double-Blind, Placebo-Controlled Multicenter Clinical Trial. Cartilage. 2018 Jul;9(3):276-283. doi: 10.1177/1947603517703732. Epub 2017 May 23. — View Citation
He WW, Kuang MJ, Zhao J, Sun L, Lu B, Wang Y, Ma JX, Ma XL. Efficacy and safety of intraarticular hyaluronic acid and corticosteroid for knee osteoarthritis: A meta-analysis. Int J Surg. 2017 Mar;39:95-103. doi: 10.1016/j.ijsu.2017.01.087. Epub 2017 Jan 27. — View Citation
Noel E, Hardy P, Hagena FW, Laprelle E, Goebel F, Faure C, Favard L, Gaudin P, Christ R, Baudot C, Dietl J, Goupille P. Efficacy and safety of Hylan G-F 20 in shoulder osteoarthritis with an intact rotator cuff. Open-label prospective multicenter study. Joint Bone Spine. 2009 Dec;76(6):670-3. doi: 10.1016/j.jbspin.2009.10.008. — View Citation
Petrella RJ, Emans PJ, Alleyne J, Dellaert F, Gill DP, Maroney M. Safety and performance of Hydros and Hydros-TA for knee osteoarthritis: a prospective, multicenter, randomized, double-blind feasibility trial. BMC Musculoskelet Disord. 2015 Mar 18;16:57. doi: 10.1186/s12891-015-0513-6. — View Citation
Petrella RJ, Petrella M. A prospective, randomized, double-blind, placebo controlled study to evaluate the efficacy of intraarticular hyaluronic acid for osteoarthritis of the knee. J Rheumatol. 2006 May;33(5):951-6. — View Citation
Samilson RL, Prieto V. Dislocation arthropathy of the shoulder. J Bone Joint Surg Am. 1983 Apr;65(4):456-60. — View Citation
Smith C, Patel R, Vannabouathong C, Sales B, Rabinovich A, McCormack R, Belzile EL, Bhandari M. Combined intra-articular injection of corticosteroid and hyaluronic acid reduces pain compared to hyaluronic acid alone in the treatment of knee osteoarthritis. Knee Surg Sports Traumatol Arthrosc. 2019 Jun;27(6):1974-1983. doi: 10.1007/s00167-018-5071-7. Epub 2018 Jul 25. — View Citation
Tammachote N, Kanitnate S, Yakumpor T, Panichkul P. Intra-Articular, Single-Shot Hylan G-F 20 Hyaluronic Acid Injection Compared with Corticosteroid in Knee Osteoarthritis: A Double-Blind, Randomized Controlled Trial. J Bone Joint Surg Am. 2016 Jun 1;98(11):885-92. doi: 10.2106/JBJS.15.00544. — View Citation
Walch G, Badet R, Boulahia A, Khoury A. Morphologic study of the glenoid in primary glenohumeral osteoarthritis. J Arthroplasty. 1999 Sep;14(6):756-60. doi: 10.1016/s0883-5403(99)90232-2. — View Citation
Zhang B, Thayaparan A, Horner N, Bedi A, Alolabi B, Khan M. Outcomes of hyaluronic acid injections for glenohumeral osteoarthritis: a systematic review and meta-analysis. J Shoulder Elbow Surg. 2019 Mar;28(3):596-606. doi: 10.1016/j.jse.2018.09.011. Epub 2018 Nov 28. — View Citation
* Note: There are 11 references in all — Click here to view all references
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in VAS score | Visual analogue score VAS; 0-10 scale, 0: no pain 10: worst possible pain | Change from baseline (preinfiltration visit) VAS score at 3 months after the infiltration | |
Secondary | Change in VAS score | Visual analogue score VAS; 0-10 scale, 0: no pain 10: worst possible pain | Change from baseline (preinfiltration visit) VAS score at 1 month after the infiltration | |
Secondary | Change in VAS score | Visual analogue score VAS; 0-10 scale, 0: no pain 10: worst pain | Change from baseline (preinfiltration visit) VAS score at 6 months after the infiltration | |
Secondary | Change in QuickDash disability/symptoms score | QuickDash; 0-100 scale, 0: no difficulties 100: unable | Change from baseline (preinfiltration visit) QuickDash score at 1 month after the infiltration | |
Secondary | Change in QuickDash disability/symptoms score | QuickDash; 0-100 scale, 0: no difficulties 100: unable | Change from baseline (preinfiltration visit) QuickDash score at 3 months after the infiltration | |
Secondary | Change QuickDash disability/symptoms score | QuickDash; 0-100 scale, 0: no difficulties 100: unable | Change from baseline (preinfiltration visit) QuickDash score at 6 months after the infiltration | |
Secondary | Change in QuickDash Work score | QuickDash; 0-100 scale, 0: no difficulties 100: unable | Change from baseline (preinfiltration visit) QuickDash score at 1 month after the infiltration | |
Secondary | Change in QuickDash Work score | QuickDash; 0-100 scale, 0: no difficulties 100: unable | Change from baseline (preinfiltration visit) QuickDash score at 3 months after the infiltration | |
Secondary | Change in QuickDash Work score | QuickDash; 0-100 scale, 0: no difficulties 100: unable | Change from baseline (preinfiltration visit) QuickDash score at 6 months after the infiltration | |
Secondary | Change in QuickDash Sport/Music score | QuickDash; 0-100 scale, 0: no difficulties 100: unable | Change from baseline (preinfiltration visit) QuickDash score at 1 month after the infiltration | |
Secondary | Change in QuickDash Sport/Music score | QuickDash; 0-100 scale, 0: no difficulties 100: unable | Change from baseline (preinfiltration visit) QuickDash score at 3 months after the infiltration | |
Secondary | Change in QuickDash Sport/Music score | QuickDash; 0-100 scale, 0: no difficulties 100: unable | Change from baseline (preinfiltration visit) QuickDash score at 6 months after the infiltration |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03540030 -
Opioid-Free Shoulder Arthroplasty
|
Phase 4 | |
Recruiting |
NCT06025331 -
Does BIO-RSA Provides Superior Clinical Outcome Compared to Conventional RSA?
|
N/A | |
Recruiting |
NCT06153381 -
Virtual Rehabilitation Assistant Via Instant Messaging Communication to Promote Adherence to Rehabilitation After Reverse Shoulder Replacement
|
N/A | |
Recruiting |
NCT04762667 -
Individual Preoperative Planning for RSA
|
N/A | |
Recruiting |
NCT06025448 -
Is MIO-RSA Noninferior to BIO-RSA When it Comes to Mechanical Implant Stability?
|
N/A | |
Completed |
NCT03854357 -
Subscapularis Strength After Total Shoulder Arthroplasty
|
N/A | |
Recruiting |
NCT05048264 -
Effect of Corticosteroid Injections on Blood Glucose
|
||
Recruiting |
NCT05395819 -
Clinical Evaluation of Reverse Versus Anatomic Shoulder Arthroplasty Techniques in the Treatment of Osteoarthritis
|
N/A | |
Recruiting |
NCT06381791 -
CBD for Pain Following Orthopedic Shoulder Surgery
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT04405297 -
A Disease-based Treatment Study for Diagnosed Osteoarthritis Utilizing Adipose-derived Regenerative Cells
|
||
Not yet recruiting |
NCT05868330 -
Comparison of Interscalene Catheter to Single Injection Interscalene Blocks for Total Shoulder Arthroplasties
|
N/A | |
Recruiting |
NCT05675527 -
PRP for Glenohumeral Osteoarthritis
|
Phase 4 | |
Recruiting |
NCT06319911 -
AETOS Shoulder System
|
||
Withdrawn |
NCT03474510 -
Effective Pain Management During Shoulder Replacement Surgery With EXPAREL
|
Phase 4 | |
Completed |
NCT05043493 -
Effect of PRP as Therapy for Shoulder Osteoarthritis
|
N/A | |
Recruiting |
NCT05788614 -
Retroversion in Reverse Shoulder Arthroplasty
|
N/A | |
Not yet recruiting |
NCT06435494 -
Cross-sectorial Use of Patient-Reported Outcomes in Chronic Degenerative Shoulder Conditions
|
N/A | |
Withdrawn |
NCT04285606 -
Effect of Postop Rehab Methods on Outcomes Following Reverse Shoulder Arthroplasty
|
N/A | |
Recruiting |
NCT04984291 -
Zimmer Biomet Shoulder Arthroplasty PMCF
|
N/A | |
Not yet recruiting |
NCT05451550 -
The Effects of General Anesthesia and Combined Anesthesia in Controlled Hypotension During Arthroscopic Shoulder Surgery
|
N/A |